BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7886081)

  • 1. Modulation of free intracellular calcium and cAMP by morphine and cannabinoids, alone and in combination in mouse brain and spinal cord synaptosomes.
    Pugh G; Welch SP; Bass PP
    Pharmacol Biochem Behav; 1994 Dec; 49(4):1093-100. PubMed ID: 7886081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine.
    Welch SP; Thomas C; Patrick GS
    J Pharmacol Exp Ther; 1995 Jan; 272(1):310-21. PubMed ID: 7815346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide.
    Houser SJ; Eads M; Embrey JP; Welch SP
    Brain Res; 2000 Feb; 857(1-2):337-42. PubMed ID: 10700588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of delta 9-tetrahydrocannabinol and other cannabinoids on cAMP accumulation in synaptosomes.
    Little PJ; Martin BR
    Life Sci; 1991; 48(12):1133-41. PubMed ID: 1848340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of free intracellular calcium levels [(Ca++)i] in brain and spinal cord of morphine-tolerant rats and mice.
    Welch SP; Bass PP
    Pharmacol Biochem Behav; 1995 May; 51(1):57-63. PubMed ID: 7617733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of dynorphin B in the antinociceptive effects of the cannabinoid CP55,940 in the spinal cord.
    Pugh G; Mason DJ; Combs V; Welch SP
    J Pharmacol Exp Ther; 1997 May; 281(2):730-7. PubMed ID: 9152379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.
    Welch SP; Dunlow LD; Patrick GS; Razdan RK
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1235-44. PubMed ID: 7791096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine-induced modulation of calcitonin gene-related peptide levels.
    Welch SP; Bass PP; Olson KG; Pugh G
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1107-16. PubMed ID: 1335576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice.
    Welch SP; Stevens DL
    J Pharmacol Exp Ther; 1992 Jul; 262(1):10-8. PubMed ID: 1320680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine tolerance-induced modulation of [3H]glyburide binding to mouse brain and spinal cord.
    Welch SP; Smith FL; Dewey WL
    Drug Alcohol Depend; 1997 Apr; 45(1-2):47-53. PubMed ID: 9179506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord.
    Pugh G; Smith PB; Dombrowski DS; Welch SP
    J Pharmacol Exp Ther; 1996 Nov; 279(2):608-16. PubMed ID: 8930163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of adenosine in the spinal antinociceptive effects of morphine and noradrenaline.
    Sweeney MI; White TD; Sawynok J
    J Pharmacol Exp Ther; 1987 Nov; 243(2):657-65. PubMed ID: 2824755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine activates omega-conotoxin-sensitive Ca2+ channels to release adenosine from spinal cord synaptosomes.
    Cahill CM; White TD; Sawynok J
    J Neurochem; 1993 Mar; 60(3):894-901. PubMed ID: 7679729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation of the antinociceptive activity of calcitonin gene-related peptide alone and in combination with morphine: correlation to 45Ca++ uptake by synaptosomes.
    Welch SP; Cooper CW; Dewey WL
    J Pharmacol Exp Ther; 1988 Jan; 244(1):28-33. PubMed ID: 3257266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opiate tolerance-induced modulation of free intracellular calcium in synaptosomes.
    Welch SP; Olson KG
    Life Sci; 1991; 48(19):1853-61. PubMed ID: 1710309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems.
    ViganĂ² D; Rubino T; Vaccani A; Bianchessi S; Marmorato P; Castiglioni C; Parolaro D
    Psychopharmacology (Berl); 2005 Nov; 182(4):527-36. PubMed ID: 16079992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of morphine tolerance and dependence by diazepam and its relation to cyclic AMP levels in discrete rat brain regions and spinal cord.
    Sheu MJ; Sribanditmongkol P; Santosa DN; Tejwani GA
    Brain Res; 1995 Mar; 675(1-2):31-7. PubMed ID: 7796144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.
    Tham SM; Angus JA; Tudor EM; Wright CE
    Br J Pharmacol; 2005 Mar; 144(6):875-84. PubMed ID: 15778704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salmon calcitonin-induced modulation of free intracellular calcium.
    Welch SP; Olson KG
    Pharmacol Biochem Behav; 1991 Jul; 39(3):641-8. PubMed ID: 1784592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoids inhibit calcium uptake by brain synaptosomes.
    Harris RA; Stokes JA
    J Neurosci; 1982 Apr; 2(4):443-7. PubMed ID: 6279797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.